Terms: = Prostate cancer AND PML, TRIM19, 5371, ENSG00000140464, MYL, PP8675, RNF71
42 results:
1. Biosensors Based on Stanniocalcin-1 Protein Antibodies Thin Films for prostate cancer Diagnosis.
Ferreira R; Ribeiro PA; Canário AVM; Raposo M
Biosensors (Basel); 2023 Nov; 13(11):. PubMed ID: 37998156
[TBL] [Abstract] [Full Text] [Related]
2. The mTOR chromatin-bound interactome in prostate cancer.
Dufour CR; Scholtes C; Yan M; Chen Y; Han L; Li T; Xia H; Deng Q; Vernier M; Giguère V
Cell Rep; 2022 Mar; 38(12):110534. PubMed ID: 35320709
[TBL] [Abstract] [Full Text] [Related]
3. SLX4IP N-terminus dictates telomeric localization in ALT-like castration-resistant prostate cancer cell lines.
Mangosh TL; Grabowska MM; Taylor DJ
Prostate; 2021 Nov; 81(15):1235-1251. PubMed ID: 34492133
[TBL] [Abstract] [Full Text] [Related]
4. SLX4IP Promotes Telomere Maintenance in Androgen Receptor-Independent Castration-Resistant prostate cancer through ALT-like Telomeric pml Localization.
Mangosh TL; Awadallah WN; Grabowska MM; Taylor DJ
Mol Cancer Res; 2021 Feb; 19(2):301-316. PubMed ID: 33188147
[TBL] [Abstract] [Full Text] [Related]
5.
Roberts MJ; Morton A; Donato P; Kyle S; Pattison DA; Thomas P; Coughlin G; Esler R; Dunglison N; Gardiner RA; Doi SA; Emmett L; Yaxley J
Eur J Nucl Med Mol Imaging; 2021 Feb; 48(2):477-482. PubMed ID: 32696091
[TBL] [Abstract] [Full Text] [Related]
6. A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells.
Auvin S; Öztürk H; Abaci YT; Mautino G; Meyer-Losic F; Jollivet F; Bashir T; de Thé H; Sahin U
Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31431473
[TBL] [Abstract] [Full Text] [Related]
7. An analysis of a multiple biomarker panel to better predict prostate cancer metastasis after radical prostatectomy.
Zhang AY; Chiam K; Haupt Y; Fox S; Birch S; Tilley W; Butler LM; Knudsen K; Comstock C; Rasiah K; Grogan J; Mahon KL; Bianco-Miotto T; Ricciardelli C; Böhm M; Henshall S; Delprado W; Stricker P; Horvath LG; Kench JG
Int J Cancer; 2019 Mar; 144(5):1151-1159. PubMed ID: 30288742
[TBL] [Abstract] [Full Text] [Related]
8. Specific expression of lncRNA RP13-650J16.1 and TCONS_00023979 in prostate cancer.
Zhou X; Chen Q; Wang H; Zhang C; Fu B; Wang G
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279207
[TBL] [Abstract] [Full Text] [Related]
9. An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer.
Chen M; Zhang J; Sampieri K; Clohessy JG; Mendez L; Gonzalez-Billalabeitia E; Liu XS; Lee YR; Fung J; Katon JM; Menon AV; Webster KA; Ng C; Palumbieri MD; Diolombi MS; Breitkopf SB; Teruya-Feldstein J; Signoretti S; Bronson RT; Asara JM; Castillo-Martin M; Cordon-Cardo C; Pandolfi PP
Nat Genet; 2018 Feb; 50(2):206-218. PubMed ID: 29335545
[TBL] [Abstract] [Full Text] [Related]
10. Deregulated PP1α phosphatase activity towards MAPK activation is antagonized by a tumor suppressive failsafe mechanism.
Chen M; Wan L; Zhang J; Zhang J; Mendez L; Clohessy JG; Berry K; Victor J; Yin Q; Zhu Y; Wei W; Pandolfi PP
Nat Commun; 2018 Jan; 9(1):159. PubMed ID: 29335436
[TBL] [Abstract] [Full Text] [Related]
11. Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.
Bezzi M; Seitzer N; Ishikawa T; Reschke M; Chen M; Wang G; Mitchell C; Ng C; Katon J; Lunardi A; Signoretti S; Clohessy JG; Zhang J; Pandolfi PP
Nat Med; 2018 Feb; 24(2):165-175. PubMed ID: 29309058
[TBL] [Abstract] [Full Text] [Related]
12. A comprehensive analysis of polymorphic variants in steroid hormone and insulin-like growth factor-1 metabolism and risk of in situ breast cancer: Results from the Breast and prostate cancer Cohort Consortium.
Barrdahl M; Canzian F; Gaudet MM; Gapstur SM; Trichopoulou A; Tsilidis K; van Gils CH; Borgquist S; Weiderpass E; Khaw KT; Giles GG; Milne RL; Le Marchand L; Haiman C; Lindström S; Kraft P; Hunter DJ; Ziegler R; Chanock SJ; Yang XR; Buring JE; Lee IM; Kaaks R; Campa D
Int J Cancer; 2018 Mar; 142(6):1182-1188. PubMed ID: 29114882
[TBL] [Abstract] [Full Text] [Related]
13. Generation of In Vitro Model of Epithelial Mesenchymal Transition (EMT) Via the Expression of a Cytoplasmic Mutant Form of Promylocytic Leukemia Protein (pml).
Di Biase A; Miles AK; Regad T
Methods Mol Biol; 2018; 1692():129-138. PubMed ID: 28986893
[TBL] [Abstract] [Full Text] [Related]
14. pml nuclear bodies contribute to the basal expression of the mTOR inhibitor DDIT4.
Salsman J; Stathakis A; Parker E; Chung D; Anthes LE; Koskowich KL; Lahsaee S; Gaston D; Kukurba KR; Smith KS; Chute IC; Léger D; Frost LD; Montgomery SB; Lewis SM; Eskiw C; Dellaire G
Sci Rep; 2017 Mar; 7():45038. PubMed ID: 28332630
[TBL] [Abstract] [Full Text] [Related]
15. Quantification of telomere features in tumor tissue sections by an automated 3D imaging-based workflow.
Gunkel M; Chung I; Wörz S; Deeg KI; Simon R; Sauter G; Jones DTW; Korshunov A; Rohr K; Erfle H; Rippe K
Methods; 2017 Feb; 114():60-73. PubMed ID: 27725304
[TBL] [Abstract] [Full Text] [Related]
16. Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6AP.
Paul PJ; Raghu D; Chan AL; Gulati T; Lambeth L; Takano E; Herold MJ; Hagekyriakou J; Vessella RL; Fedele C; Shackleton M; Williams ED; Fox S; Williams S; Haupt S; Gamell C; Haupt Y
Oncogene; 2016 Dec; 35(48):6235-6245. PubMed ID: 27641331
[TBL] [Abstract] [Full Text] [Related]
17. A CDK4/6-Dependent Epigenetic Mechanism Protects cancer Cells from pml-induced Senescence.
Acevedo M; Vernier M; Mignacca L; Lessard F; Huot G; Moiseeva O; Bourdeau V; Ferbeyre G
Cancer Res; 2016 Jun; 76(11):3252-64. PubMed ID: 27206849
[TBL] [Abstract] [Full Text] [Related]
18. Cytoplasmic pml promotes TGF-β-associated epithelial-mesenchymal transition and invasion in prostate cancer.
Buczek ME; Miles AK; Green W; Johnson C; Boocock DJ; Pockley AG; Rees RC; Hulman G; van Schalkwyk G; Parkinson R; Hulman J; Powe DG; Regad T
Oncogene; 2016 Jun; 35(26):3465-75. PubMed ID: 26549027
[TBL] [Abstract] [Full Text] [Related]
19. A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours.
Kalathur M; Toso A; Chen J; Revandkar A; Danzer-Baltzer C; Guccini I; Alajati A; Sarti M; Pinton S; Brambilla L; Di Mitri D; Carbone G; Garcia-Escudero R; Padova A; Magnoni L; Tarditi A; Maccari L; Malusa F; Kalathur RK; A Pinna L; Cozza G; Ruzzene M; Delaleu N; Catapano CV; Frew IJ; Alimonti A
Nat Commun; 2015 Jun; 6():7227. PubMed ID: 26085373
[TBL] [Abstract] [Full Text] [Related]
20. Expression of E6AP and pml predicts for prostate cancer progression and cancer-specific death.
Birch SE; Kench JG; Takano E; Chan P; Chan AL; Chiam K; Veillard AS; Stricker P; Haupt S; Haupt Y; Horvath L; Fox SB
Ann Oncol; 2014 Dec; 25(12):2392-2397. PubMed ID: 25231954
[TBL] [Abstract] [Full Text] [Related]
[Next]
